Supreme Court Rejects “Statistical Significance” as Threshold for Required Securities Disclosure
In Matrixx Initiatives et al. v. Siracusano et al, the unanimous Court held that a pharmaceutical company may be liable for securities fraud by failing to disclose a statistically insignificant number of adverse reactions to a cold medication. The Supreme Court issued a decision on March 22, 2011 that may help securities class action plaintiffs…